drugset / Trial / NCT00359840
A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the clinical effective dose of KRN321 administered with once triweekly schedule.
Timeline
- Start
- 2006-07
- Primary completion
- 2007-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darbepoetin alfa | Protein / enzyme biologic | — | — |